Close Menu

NEW YORK (GenomeWeb) — MDxHealth reported today flat year-over-year revenues for 2018 amid a decline in US test volume of its flagship ConfirmMDx prostate cancer tissue test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.